WORK Medical Technology (WOK) Operating Leases (2023 - 2025)

WORK Medical Technology's (WOK) quarterly Operating Leases came in at $18756.0 in Q3 2025, up 9.01% on a QoQ basis from $17205.0 in Q1 2025.

WORK Medical Technology (WOK) Operating Leases (2023 - 2025) Analysis & Trends

WORK Medical Technology (WOK) has 2 years of Operating Leases data on file, last reported at $18756.0 in Q3 2025.

Quarterly Operating Leases changed N/A year-over-year to $18756.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $18756.0 (changed N/A YoY) and the FY2025 annual result came in at $18756.0, changed N/A from the prior year.
Operating Leases improved to $18756.0 in Q3 2025, from $17205.0 in the prior quarter.
In the past five years, Operating Leases ranged from a high of $50130.0 in Q3 2023 to a low of $17205.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.61 Bn	194.01 Bn	7.27 Bn
2	Stryker	127.81 Bn	124.34 Bn	4.50 Bn
3	Medtronic	119.04 Bn	109.82 Bn	6.41 Bn
4	Boston Scientific	73.68 Bn	73.14 Bn	3.85 Bn
5	Edwards Lifesciences	51.96 Bn	47.71 Bn	1.35 Bn
6	Dexcom	34.36 Bn	32.41 Bn	830.00 Mn
7	GE HealthCare Technologies	33.83 Bn	31.72 Bn	2.18 Bn
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn
9	Steris	23.06 Bn	22.58 Bn	684.20 Mn
10	WORK Medical Technology	626,039.30	-2.63 Mn	-

Download Data